Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36, N.5, and our video podcast, CANCER BUZZ TV.

TxSCO is raising its advocacy voice on state and federal issues.

We are actively working to ensure that the voice of oncology in Texas is heard. Explore our website for the latest updates in oncology and healthcare-related legislation in Texas, discover TxSCO's advocacy on the state and federal level, and more. 

TxSCO values your input. Help us make a difference in our state. Do you know a Texas State Legislature member? Do you have an issue you want to bring attention to? Please send all questions and comments to Nicole Rodin, Executive Director.

State Advocacy

TxSCO Joins ASCO in Support Letter for HB 293

The Texas Society of Clinical Oncology (TxSCO) and the Association for Clinical Oncology (ASCO) are pleased to support House Bill 293: Relating to health benefit coverage for certain fertility preservation services under certain health benefit plans, which would provide coverage for fertility preservation services for patients with cancer when necessary medical treatments may cause infertility. The House Insurance Committee’s passage of HB 293 would be a crucial step in helping to make Texas the 11th state to provide this important protection for patients with cancer. Read support letter

Posted 03/18/2021

 

Federal Advocacy

Federal and State Advocacy Updates—October 2021
  • Federal
    • Drug Pricing Reforms
      • "Build Back Better Act" also known as the reconciliation bill, is currently under debate by congressional committees.
      • Administrative action looms
    • Federal Policy Outlook
      • Part B drug reimbursement under threat
      • Oncology Care Model in limbo
      • Medicare 2% sequestration extension
  • State
    • Special Session Update
    • Statewide Campaign Update

View Full Report

 
Federal and State Advocacy Updates—September 2021
  • Federal
    • Drug Pricing Reforms
      • Latest developments, intel
    • Physician-Administered Drugs
      • Employer payments to HOPDs are three times the physician office rate
      • Hospitals spend $310 million/year on white and brown bagging requirements
    • Prior Authorization Update
      • Anthem's "Dose Reduction" program
  • State
    • Special Session Update
    • TDI Updates
    • COVID-19 Update

View Full Report

 
Federal and State Advocacy Updates—August 2021
  • Federal
    • Drug Pricing Reforms
      • Latest developments, intel
    • Most Favored Nation
      • CMS proposes to formally rescind
    • Notable Rules
      • Radiation Therapy Model, OPPS, PFS
    • Utilization Management
      • Health affairs study
  • State
    • COVID in Texas
    • COVID Bill Refresher
    • TDI Implementation
    • TMB Emergency Prescription Rule
    • Special Session Update
    • Senate HHS Hearing
    • Palliative Care Council

View Full Report

 

Update for MIPS-Eligible Clinicians Affected by Extreme Circumstances

In response to the Federal Emergency Management Agency (FEMA) designation of the Texas Severe Winter Storm as a national disaster, the Centers for Medicare & Medicaid Services has determined that the automatic extreme and uncontrollable circumstances policy will apply to Merit-based Incentive Payment System (MIPS) eligible clinicians in FEMA-identified Texas areas.

MIPS-eligible clinicians in these areas will be automatically identified and receive a neutral payment adjustment for the 2023 MIPS payment year. During the data submission period for the 2021 performance period (January 3, 2022 to March 31, 2022), all four performance categories for these clinicians will be weighted at zero percent, resulting in a score equal to the performance threshold. Click here for more information.

Posted 05/13/2021

 

1801 Research Boulevard Suite 400
Rockville, MD 20850
Tel: 301.984.9496 | Fax: 301.770.1949
txsco.com
Email Us